Novo Nordisk adding in-house fill-finish capacity for Wegovy’s European pen, Ozempic

[ad_1] The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little//File Photo Acquire Licensing Rights LONDON, Nov 2 (Reuters) – Novo Nordisk (NOVOb.CO) is ramping up…

How Novo Nordisk makes its weight-loss drug Wegovy

[ad_1] [1/2]A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August31, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights LONDON,…

Abbott says market overestimating sales hit from new diabetes drugs

[ad_1] Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights…

Breakingviews – Siemens is case study in China de-risking dilemma

[ad_1] LONDON, Oct 4 (Reuters Breakingviews) – Roland Busch has a problem familiar to many German corporate chieftains. Siemens’ (SIEGn.DE) chief executive presides over a sprawling $110 billion conglomerate with…

Exor to buy back 1 bln euro own shares, starts with 750 mln tender offer on Thursday

[ad_1] Exor logo is displayed in this illustration taken September 5, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Cap price for reverse tender offer set at 89.17 euros Exor shares…

Agnelli family’s Exor buys $2.8 bln stake in Philips

[ad_1] [1/2]Philips Healthcare headquarters is seen in Best, Netherlands August 30, 2018. Picture taken August 30, 2018. REUTERS/Piroschka van de Wouw/File Photo Italy’s Exor takes 15%, with option to increase…

Exclusive: ValueAct names Hale co-CEO, announces partner departures, strong gains

[ad_1] NEW YORK, Aug 4 (Reuters) – ValueAct Capital is reordering its management team and promoting long-time partner Robert Hale to co-chief executive alongside Mason Morfit as the investment firm…

European stocks hit record highs after rising for sixth day

[ad_1] Siemens Healthineers up on raising synergy targets Europe Inc profits expected to rise 60.4% Gaming firm Evolution drags down travel stocks Nov 17 (Reuters) – European stocks closed at…

Illumina CEO Francis deSouza resigns after battle with Icahn

[ad_1] June 11 (Reuters) – Illumina (ILMN.O) Chief Executive Officer Francis deSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor…

Exclusive: Warburg and Advent in the lead to acquire Baxter’s biopharma unit-sources

[ad_1] NEW YORK, May 7 (Reuters) – A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s (BAX.N)…